S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
OTCMKTS:BETRF

BetterLife Pharma (BETRF) Stock Forecast, Price & News

$0.06
+0.00 (+7.41%)
(As of 05:17 PM ET)
Compare
Today's Range
$0.06
$0.06
50-Day Range
$0.05
$0.07
52-Week Range
$0.03
$0.19
Volume
35,003 shs
Average Volume
34,226 shs
Market Capitalization
$5.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BETRF stock logo

About BetterLife Pharma (OTCMKTS:BETRF) Stock

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's pipeline products include BETR-001 for the treatment of major depressive disorder, treatment resistance depression, cluster headaches, and post-traumatic stress disorder; and BETR-002 to treat benzodiazepine dependency, anxiety, and spasticity. It is also developing MM-003 for treatment of COVID-19 and other respiratory viral infections; MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and AP-002 for the treatment of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Receive BETRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter.

BETRF Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
BetterLife Closes $1,857,143 of Private Placement
BetterLife Announces Offering of Units
See More Headlines

BETRF Price History

BETRF Company Calendar

Today
6/09/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BETRF
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-6,900,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.07) per share

Miscellaneous

Free Float
55,707,000
Market Cap
$4.95 million
Optionable
Not Optionable
Beta
1.50

Key Executives

  • Dr. Ahmad Doroudian Ph.D. (Age 63)
    Founder, CEO & Chairman
    Comp: $300k
  • Ms. Moira Ong C.A. (Age 48)
    CPA, CA, CFA, Chief Financial Officer
    Comp: $264k
  • Dr. Hooshmand Sheshbaradaran Ph.D. (Age 55)
    Chief Operating Officer
    Comp: $341.37k
  • Mr. Scott Rudge Ph.D.
    Head of CMC
  • Anthony Calandra Ph.D.
    Head of Regulatory
  • Dr. Abdi Ghaffari Ph.D.
    Head of Preclinical & Toxicology













BETRF Stock - Frequently Asked Questions

How have BETRF shares performed in 2023?

BetterLife Pharma's stock was trading at $0.1216 at the beginning of 2023. Since then, BETRF shares have decreased by 52.3% and is now trading at $0.0580.
View the best growth stocks for 2023 here
.

What is BetterLife Pharma's stock symbol?

BetterLife Pharma trades on the OTCMKTS under the ticker symbol "BETRF."

How do I buy shares of BetterLife Pharma?

Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BetterLife Pharma's stock price today?

One share of BETRF stock can currently be purchased for approximately $0.06.

How much money does BetterLife Pharma make?

BetterLife Pharma (OTCMKTS:BETRF) has a market capitalization of $4.95 million. The company earns $-6,900,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis.

How can I contact BetterLife Pharma?

BetterLife Pharma's mailing address is 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6. The official website for the company is www.abetterlifepharma.com. The company can be reached via phone at 604-221-0595 or via email at ir@blifepharma.com.

This page (OTCMKTS:BETRF) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -